Literature DB >> 31403931

Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light.

Nahreen Tynngård1, Agneta Wikman2,3, Michael Uhlin2,4, Per Sandgren2,4.   

Abstract

BACKGROUND: Due to the risk of replication of contaminating pathogens, platelets have a limited storage time of 5 days, which can be prolonged to 7 days by the use of pathogen inactivation technologies. Cryopreservation (CP) may be an alternative to permit longer storage periods and increased availability. However, the preparation of platelets can result in secretion of biological response modifiers (BRM), which can cause adverse transfusion reactions in the recipient. We investigated the impact of CP on platelet function and release of BRM in untreated (conventional) and pathogen-inactivated (PI) platelet concentrates.
MATERIALS AND METHODS: Twelve buffy coat-derived platelet units were treated with amotosalen and ultraviolet A light to inactivate pathogens. Twelve untreated units were used as controls. The 24 units were cryopreserved and in vitro variables were analysed before and after CP. The in vitro variables investigated included platelet surface receptors and activation markers by flow cytometry, and coagulation time by viscoelastography. A panel of BRM, including cytokines, was investigated.
RESULTS: CP of both conventional and PI platelets resulted in a significant increase of BRM with similar increases of most of the BRM after CP of conventional and PI platelet concentrates. The increase in some of the BRM correlated significantly with shortened coagulation time, increased P-selectin expression, reduced mitochondrial transmembrane potential, and reduced capacity to respond to stimulation with ADP and collagen. DISCUSSION: Cryopreservation of both conventional and PI platelets results in secretion of BRM. The increase in some of the BRM correlated with changes in platelet function variables and suggests that BRM release is affected, in part, in a similar way by CP as are changes in platelet function variables. PI with amotosalen and ultraviolet A light in combination with CP did not affect the release of immunomodulatory factors more than CP alone did.

Entities:  

Year:  2019        PMID: 31403931      PMCID: PMC7250687          DOI: 10.2450/2019.0061-19

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  44 in total

1.  Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.

Authors:  Susanne M Picker; Volker Schneider; Birgit S Gathof
Journal:  Transfusion       Date:  2009-02-10       Impact factor: 3.157

2.  Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass.

Authors:  S F Khuri; N Healey; H MacGregor; M R Barnard; I O Szymanski; V Birjiniuk; A D Michelson; D R Gagnon; C R Valeri
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

3.  Cryopreservation of buffy coat-derived platelet concentrates photochemically treated with amotosalen and UVA light.

Authors:  Stephan Meinke; Agneta Wikman; Gunilla Gryfelt; Kjell Hultenby; Michael Uhlin; Petter Höglund; Per Sandgren
Journal:  Transfusion       Date:  2018-10-03       Impact factor: 3.157

4.  Role of mitochondria in the maintenance of platelet function during in vitro storage.

Authors:  T Hayashi; S Tanaka; Y Hori; F Hirayama; E F Sato; M Inoue
Journal:  Transfus Med       Date:  2011-01-06       Impact factor: 2.019

Review 5.  The cellular basis of platelet secretion: Emerging structure/function relationships.

Authors:  Shilpi Yadav; Brian Storrie
Journal:  Platelets       Date:  2016-12-23       Impact factor: 3.862

Review 6.  Review of in vivo studies of dimethyl sulfoxide cryopreserved platelets.

Authors:  Sherrill J Slichter; Melinh Jones; Janet Ransom; Irena Gettinger; Mary Kay Jones; Todd Christoffel; Esther Pellham; S Lawrence Bailey; Jill Corson; Doug Bolgiano
Journal:  Transfus Med Rev       Date:  2014-09-21

7.  In vitro comparison of cryopreserved and liquid platelets: potential clinical implications.

Authors:  Lacey Johnson; Michael C Reade; Ryan A Hyland; Shereen Tan; Denese C Marks
Journal:  Transfusion       Date:  2014-11-05       Impact factor: 3.157

8.  Cryopreserved platelets demonstrate reduced activation responses and impaired signaling after agonist stimulation.

Authors:  Lauren Waters; Matthew P Padula; Denese C Marks; Lacey Johnson
Journal:  Transfusion       Date:  2017-09-14       Impact factor: 3.157

9.  The role of the plasma from platelet concentrates in transfusion reactions.

Authors:  N M Heddle; L Klama; J Singer; C Richards; P Fedak; I Walker; J G Kelton
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

10.  Biological response modifiers in photochemically pathogen-reduced versus untreated apheresis platelet concentrates.

Authors:  Annette Vetlesen; Mohammad Reza Mirlashari; Ciğdem Akalın Akkök; Marguerite R Kelher; Samina Y Khan; Christopher C Silliman; Jens Kjeldsen-Kragh
Journal:  Transfusion       Date:  2012-05-07       Impact factor: 3.157

View more
  3 in total

Review 1.  Platelet Biochemistry and Morphology after Cryopreservation.

Authors:  Katrijn R Six; Veerle Compernolle; Hendrik B Feys
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

2.  Cryopreservation of buffy coat derived platelets: Paired in vitro characterization using uncontrolled versus controlled freezing rate protocols.

Authors:  Nahreen Tynngård; Alice Bell; Gunilla Gryfelt; Stefan Cvetkovic; Agneta Wikman; Michael Uhlin; Per Sandgren
Journal:  Transfusion       Date:  2020-12-21       Impact factor: 3.157

Review 3.  Platelet Transfusion-Insights from Current Practice to Future Development.

Authors:  Annina Capraru; Katarzyna Aleksandra Jalowiec; Cesare Medri; Michael Daskalakis; Sacha Sergio Zeerleder; Behrouz Mansouri Taleghani
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.